Back
SpringWorks Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
SWTX
SpringWorks Therapeutics
Last Price:
$49.03
Seasonality Move:
-8.46%
7 Day Trial
ALL ACCESS PASS
$
7

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and SWTX is experiencing slight buying pressure.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.49 | Sell |
20-day SMA: | 53.71 | Sell |
50-day SMA: | 44.95 | Buy |
200-day SMA: | 38.74 | Buy |
8-day EMA: | 50.91 | Sell |
20-day EMA: | 50.89 | Sell |
50-day EMA: | 46.89 | Buy |
200-day EMA: | 40.44 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.14 | Buy |
Relative Strength Index (14 RSI): | 49.32 | Sell |
Chaikin Money Flow: | 396406 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.91 - 57.87) | Sell |
Bollinger Bands (100): | (31.98 - 48.68) | Buy |
SpringWorks Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 49.84 while SWTX 8-day simple moving average is 50.49, which is a Sell signal.
-
The stock price of SWTX is 49.84 while SpringWorks Therapeutics 20-day SMA is 53.71, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 44.95 while SWTX share price is 49.84, making it a Buy technically.
-
SWTX stock price is 49.84 and SpringWorks Therapeutics 200-day simple moving average is 38.74, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
39
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $49.84. The Score for SWTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.7B
Price in USD:
49.84
Share Volume:
1.4M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
39
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 49.84 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 49.84 while SWTX 8-day exponential moving average is 50.91, which is a Sell signal.
-
The stock price of SWTX is 49.84 while SpringWorks Therapeutics 20-day EMA is 50.89, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 46.89 while SWTX share price is 49.84, making it a Buy technically.
-
SWTX stock price is 49.84 and SpringWorks Therapeutics 200-day simple moving average is 40.44, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is 1.14, suggesting SpringWorks Therapeutics is a Buy
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 49.32, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (47.91 - 57.87), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (31.98 - 48.68), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.